References
- Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012;96(5):614–618.
- Gheorghe A, Pop M, Burcea M, et al. New clinical application of amniotic membrane transplant for ocular surface disease. J Med Life. 2016;9(2):177–179.
- Walkden A. Amniotic membrane transplantation in ophthalmology: an updated perspective. Clin Ophthalmol. 2020;14:2057–2072.
- Paolin A, Cogliati E, Trojan D, et al. Amniotic membranes in ophthalmology: long term data on transplantation outcomes. Cell Tissue Bank. 2016;17(1):51–58.
- Baylis O, Figueiredo F, Henein C, et al. 13 years of cultured limbal epithelial cell therapy: A review of the outcomes. J Cell Biochem. 2011;112(4):993–1002.
- Tseng SCG, Chen SY, Shen YC, et al. Critical appraisal of ex vivo expansion of human limbal epithelial stem cells. Curr Mol Med. 2010; 10(9):841–850.
- Schulze-Bonsel K, Feltgen N, Burau H, et al. Visual acuities “hand motion” and “counting fingers” can be quantified with the Freiburg visual acuity test. Invest Ophthalmol Vis Sci. 2006; 47(3):1236–1240.
- Schuerch K, Baeriswyl A, Frueh BE, et al. Efficacy of amniotic membrane transplantation for the treatment of corneal ulcers. Cornea. 2020; 39(4):479–483.
- Fernandez-Buenaga R, Aiello F, Zaher SS, et al. Twenty years of limbal epithelial therapy: an update on managing limbal stem cell deficiency. BMJ Open Ophth. 2018;3(1):e000164.
- Pellegrini G, Traverso CE, Franzi AT, et al. Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium. Lancet. 1997;349(9057):990–993
- Osei-Bempong C, Henein C, Ahmad S. Culture conditions for primary human limbal epithelial cells. Regen Med. 2009 May;4(3):461–470. PMID: 19438320.
- Nieto-Nicolau N, Martínez-Conesa EM, Velasco-García AM, et al. Xenofree generation of limbal stem cells for ocular surface advanced cell therapy. Stem Cell Res Ther. 2019;10(1):374.
- Sharma N, Mohanty S, Jhanji V, et al. Amniotic membrane transplantation with or without autologous cultivated limbal stem cell transplantation for the management of partial limbal stem cell deficiency. OPTH. 2018;12:2103–2106.
- Borderie VM, Ghoubay D, Georgeon C, et al. Long-term results of cultured limbal stem cell versus limbal tissue transplantation in stage III limbal deficiency . Stem Cells Transl Med. 2019;8(12):1230–1241.
- Mead OG, Tighe S, Tseng SC. Amniotic membrane transplantation for managing dry eye and neurotrophic keratitis. Taiwan J Ophthalmol. 2020;10(1):13–21.
- Touhami A, Grueterich M, Tseng SC. The role of NGF signaling in human limbal epithelium expanded by amniotic membrane culture. Invest Ophthalmol Vis Sci. 2002;43(4):987–994.
- Kheirkhah A, Raju VK, Tseng SC. Minimal conjunctival limbal autograft for total limbal stem cell deficiency. Cornea. 2008;27(6):730–733.
- Wright B, Hopkinson A, Leyland M, et al. The secretome of alginate-encapsulated limbal epithelial stem cells modulates corneal epithelial cell proliferation. PLoS One. 2013;8(7):e70860. PMID: 23894686; PMCID: PMC3722209.
- BeníTez-del-Castillo J´M, Acosta MC, Wassfi MA, et al. Relation between corneal innervation with confocal microscopy and corneal sensitivity with noncontact esthesiometry in patients with dry eye. Invest Ophthalmol Vis Sci. 2007;48(1):173–181. doi:.
- Pellegrini G, Rama P, Matuska S, et al. Biological parameters determining the clinical outcome of autologous cultures of limbal stem cells. Regen Med. 2013;8(5):553–567.
- Shortt AJ, Bunce C, Levis HJ, et al. Three-year outcomes of cultured limbal epithelial allografts in aniridia and Stevens-Johnson syndrome evaluated using the clinical outcome assessment in surgical trials assessment tool. Stem Cells Transl Med. 2014;3(2):265–275.